New research in epigenetics reveals how early-life experiences influence gene expression and brain development.

Making smart grid technologies more user-friendly keeps the its usage increasing. A recent report from MarketsandMarkets said ...

Sangamo (SGMO) stock faces challenges as Pfizer terminates partnership for hemophilia A gene therapy, impacting share price ...

The biotech company intends to explore ways to move ahead with developing the treatment, including seeking a new collaborator ...

Heading into 2025, there are multiple fronts where innovative tech marvels will lead the next evolution of global living as ...

Diabetes drugs now represent over 75% of total sales in the metabolic disorders market, up from below 40% ten years ago. The ...

The EMA's human medicines advisory committee has recommended that BioMarin Pharmaceutical's haemophilia A gene therapy Roctavian ... armed with new data from a phase 3 trial, but set back its ...

PTC Therapeutic's Upstaza gene therapy for patients with genetic ... an effective treatment for children with the disorder, the big question is whether PTC can build a commercially viable ...

As we begin 2025, we look back on all of the Huntington’s disease research news and progress the field has made in the last ...

A new study conducted at the Scojen Institute for Synthetic Biology at Reichman University's Dina Recanati School of Medicine ...

Our brain is arguably the organ that most distinguishes humans from other primates. Its exceptional size, complexity and ...

Our brain is arguably the organ that most distinguishes humans from other primates. Its exceptional size, complexity and capabilities far exceed those of any other species on Earth. Yet humans share ...